Log In
BCIQ
Print this Print this
 

PD0325901

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionMEK inhibitor
Molecular Target MEK
Mechanism of ActionMEK inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today